Director/PDMR Shareholding | RNS | Ticker

/News/RNS

Director/PDMR Shareholding

RNS Announcement

RNS Number : 2189N

GlaxoSmithKline PLC

21 October 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

Details of PDMR/person closely associated with them ('PCA')

Name

Dr M M Slaoui

Position/status

Chairman, Global Vaccines

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
$41.4815	10.943

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-20

Place of the transaction

NYSE (XNYS)

Details of PDMR/person closely associated with them ('PCA')

Name

Mr D E Troy

Position/status

SVP & General Counsel

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
$41.4815	1,196.207

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-20

Place of the transaction

New York Stock Exchange (XNYS)

Details of PDMR/person closely associated with them ('PCA')

Name

Dr K Slaoui

Position/status

PCA of Dr M M Slaoui (Chairman, Global Vaccines)

Initial notification/

amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

GlaxoSmithKline plc

LEI

5493000HZTVUYLO1D793

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

Description of the financial instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

Nature of the transaction

Acquisition of ADSs following the re-investment of dividends paid to shareholders on 13 October 2016.

Price(s) and

volume(s)

Price(s)	Volume(s)
$41.4815	26.393

Aggregated information

Aggregated volume Price

n/a (single transaction)

Date of the transaction

2016-10-20

Place of the transaction

NYSE (XNYS)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEFLFLQBFFFBB

RNS metadata

Title: Director/PDMR Shareholding
Time: 17:12:01
Date: 21 Oct 2016
Category: Director/PDMR dealings
ID: 2189N